Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Subscribe
    Home»BioTech»Cryoviva Singapore Gets AABB Accreditation for Somatic Cells’ Processing, Storage, and Distribution
    BioTech

    Cryoviva Singapore Gets AABB Accreditation for Somatic Cells’ Processing, Storage, and Distribution

    Marie JonesBy Marie JonesNovember 2, 2021No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Family cord blood bank Cryoviva Singapore is pleased to announce that it has now been accredited by the Association of the Advancement of Blood & Biotherapies (AABB), formerly known as the American Association of Blood Banks, for both cord blood and somatic cells’ banking services. Cryoviva is the first family cord blood bank in Singapore to get accredited by AABB for Somatic Cells’ processing, storage, and distribution.

    The company had already been accredited by AABB previously for Cord blood collection, storage, processing and distribution, an accreditation that has been successfully extended until September 30, 2023.

    The news of the AABB accreditation for both cord blood and somatic cells’ services closely follows Cryoviva’s recent expansions into the Middle East. The company is now serving families in the UAE and Bahrain, enabling them to store their baby’s precious umbilical cord blood at Cryoviva’s world-class facilities in Singapore.

    “We are indeed proud to get the AABB accreditations and being the first private cord blood bank to get it for somatic cells’ processing, storage and distribution. It has been our constant endeavour to offer families the greatest opportunities to benefit from the potential of umbilical cord stem cells,” said Rajesh Nair, CEO of Cryoviva Singapore. “Cord tissue storage- in addition to cord blood banking- is a significant step in this regard, which we believe will benefit a lot more families. We will continue to invest in the right technologies, processes and people to ensure we offer the very best service to our valued customers.”

    “Since commencing our operations in Singapore 7 years ago, Cryoviva has made rapid progress in establishing itself in the family cord blood space. This is another important milestone for us. Besides the company’s management and investors, our team of medical experts and lab staff deserve credit for their commitment to quality and excellence,” said Dr.Toh Keng Kiat, Medical Director of Cryoviva Singapore and a reputed haematologist.

    About Cryoviva Singapore

    Established in 2014, Cryoviva (https://cryoviva.com.sg) is a reputed family cord blood bank in Singapore. The company is part of an international group that is backed by reputed multinational investor organisations. Cryoviva has successfully stored over 160,000 umbilical cord blood units from both local and expat clients at our state-of-the-art laboratory and storage facility in Singapore. This facility is MoH-licensed, AABB accredited and IS ISO 9001:2015 QMS Certified, testaments to the stringent processes and quality standards that we adhere to. Thanks to being centrally located and proximity to most major maternity hospitals in Singapore, cord blood samples reach our facilities very quickly and efficiently to ensure top quality maintenance upon storage.

    Media Contact:
    Krish Sharma, Sr.Manager, Marketing & Operations
    Tel: +65-9651 7080
    E-mail: krish@cryoviva.com.sg

    AABB Accreditation Cryoviva Singapore Family cord blood bank
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticlePertamina supports achievement of Indonesia’s carbon emissions target
    Next Article Regional insurtech Igloo named among “2021 Inclusive Fintech 50”

    Related Posts

    Garuda Indonesia Advances Digital Transformation, Expands Travel Flexibility with Upgraded Manage My Booking Service

    October 30, 2026

    Rasa Light Je: Spritzer Sparkling Invites Malaysians to Go Light on Themselves with a Positive Approach to Everyday Wellbeing

    October 30, 2026

    Garuda Indonesia Group’s Transformation Programme Drives 13.2% Revenue Growth to US$2.71 Billion Amid High Jet Fuel Prices

    October 30, 2026
    Add A Comment

    Comments are closed.

    Latest News

    • Garuda Indonesia Advances Digital Transformation, Expands Travel Flexibility with Upgraded Manage My Booking Service
    • Chervon Launches Advanced Momentum Program (AMP) to Hire & Develop the Next Generation of Leaders
    • Autumn Lighting Fair, Outdoor and Tech Light Expo, Eco Expo Asia draw some 62,000 buyers
    • OMRON Healthcare Begins Full-Scale Production at First Factory in India
    • Rasa Light Je: Spritzer Sparkling Invites Malaysians to Go Light on Themselves with a Positive Approach to Everyday Wellbeing
    • Garuda Indonesia Group’s Transformation Programme Drives 13.2% Revenue Growth to US$2.71 Billion Amid High Jet Fuel Prices
    • CIMC Group Announces Results for the First Three Quarters of 2026
    • TANAKA MIRAI Lab., JAF MEDIA WORKS, and Della Begin Joint Research to Visualize Drivers’ Conditions through Analysis of Sweat Components
    • U.S. Polo Assn. Executes Early on Europe’s Digital Product Passport Mandate
    • COSCO SHIPPING Ports Announces 2026 Third Quarter Results
    © 2026 BusinessNewsAsia.com

    Type above and press Enter to search. Press Esc to cancel.